Publishing software and services provider Ingenta says that the 1.5p a share final dividend goes ex-dividend on 30 May.
In 2018, revenues fell from £14.7m to £12m, while a £800,000 profit was turned into a £1.23m loss. That was partly due to a rise in reorganisation costs from £301,000 to £840,000. The dividend was unchanged.
There was £2.5m in the bank at the end of January 2019 after a strong cash flow. Cash generated from operations last year was taken up by research and development spending and reorganisation costs.
The benefits from the reorganisation should show through this year.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.